Licenses and Copyright Policy
All content published in the Journal is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). This license permits:
• Unrestricted use, distribution, and reproduction in any medium,
• Provided that the original work is properly cited,
• For non-commercial purposes only.
1. Copyright Retention:
• Authors retain the copyright to their work.
• Upon acceptance, authors grant the Journal a non-exclusive license to publish, disseminate, and archive the article.
2. Third-Party Content:
• Authors are required to obtain and provide written permission for the use of any copyrighted material, such as figures, tables, or datasets.
• The use of any content without permission will be considered a copyright violation and may result in immediate rejection or retraction of the manuscript.
TR DİZİN ULAKBİM and International Indexes (1b)
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/3449/file/4924/show
Journal Indexes and Platforms:
TR Dizin ULAKBİM, Google Scholar, Crossref, Worldcat (OCLC), DRJI, EuroPub, OpenAIRE, Turkiye Citation Index, Turk Medline, ROAD, ICI World of Journal's, Index Copernicus, ASOS Index, General Impact Factor, Scilit.The indexes of the journal's are;
|
|
|
|
The platforms of the journal's are;
|
| |
|
The indexes/platforms of the journal are;
TR Dizin Ulakbim, Crossref (DOI), Google Scholar, EuroPub, Directory of Research Journal İndexing (DRJI), Worldcat (OCLC), OpenAIRE, ASOS Index, ROAD, Turkiye Citation Index, ICI World of Journal's, Index Copernicus, Turk Medline, General Impact Factor, Scilit
Journal articles are evaluated as "Double-Blind Peer Review"
All articles published in this journal are licensed under a Creative Commons Attribution 4.0 International License (CC BY NC ND)